Viewing nowAdphen Tablets (Phenmetrazine Tartrate)
Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

MFDS item code 200512153 · Approved 2005.11.09
Short-term weight loss adjunct therapy for obesity (including high body weight and risk factors)
This medication is used as a short-term adjunct treatment for obese patients in the early stages who do not respond to appropriate dietary and exercise therapy. It is especially recommended for patients with a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who also have accompanying risk factors such as hypertension, diabetes, or hyperlipidemia. It aids in the treatment of exogenous obesity that is based on calorie restriction, and it should only be taken alone without the use of other appetite suppressants. The patient's BMI is calculated by dividing their weight (kg) by the square of their height (m), which helps determine the need for treatment. This medication effectively assists in weight loss to improve obesity.
As Phenmetrazine Tartrate, 35 mg should be taken orally 2-3 times a day, 1 hour before meals. The dosage should use the minimum effective dose and be adjusted individually. For some patients, 17.5 mg once daily may be appropriate. Do not exceed 70 mg in a single dose or take it more than 3 times a day. It should be administered for a short-term (within 4 weeks), and treatment can be continued if satisfactory weight loss is achieved within 4 weeks.
This medication may cause serious heart problems if used with other appetite suppressants, so it must be used alone and only for a short period. Long-term use of this medication significantly increases the risk of a rare disease called pulmonary arterial hypertension, so if symptoms such as shortness of breath or angina occur, the patient should immediately stop taking the medication and seek medical care. Those with heart valve issues or heart murmurs should avoid using this medication, and it is important to accurately assess heart condition before administration. This medication should not be administered to patients with certain diseases or conditions, such as cardiovascular disease, hypertension, hyperthyroidism, glaucoma, individuals with mental anxiety states, and those with a history of substance abuse. Children under 16 years of age and women who are pregnant or may become pregnant should not take this medication. As this medication affects the central nervous system, it can cause symptoms such as anxiety, headache, and insomnia, so caution is needed when performing tasks that require concentration, such as driving or operating machinery. Diabetic patients may need to adjust their insulin dosage while taking this medication, so they should consult their physician. In cases of overdose, severe symptoms such as extreme anxiety, coma, seizures, abnormal blood pressure, and vomiting may occur, so immediate emergency treatment is necessary. This medication should be kept out of the reach of children, and due to the risk of drug dependence, it should be taken exactly as directed by a doctor. It is safe for pregnant or breastfeeding women not to take this medication; if necessary, they must consult a physician.
Rash
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, the medication should be kept away from excessively hot or cold places, ideally at a normal room temperature between 1 to 30 degrees.
White round tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPhendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Albuzene Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.